Recombinant
RabMAb

Anti-G Protein alpha x+z antibody [EPR8654] (ab154846)

Overview

  • Product name
    Anti-G Protein alpha x+z antibody [EPR8654]
    See all G Protein alpha x+z primary antibodies
  • Description
    Rabbit monoclonal [EPR8654] to G Protein alpha x+z
  • Tested applications
    Suitable for: WBmore details
    Unsuitable for: ICC/IF,IHC-P or IP
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide corresponding to residues in Human G Protein alpha x+z (Uniprot: P19086)

  • Positive control
    • Human fetal brain, human cerebellum, rat brain and mouse brain lysates.
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents

Properties

Applications

Our Abpromise guarantee covers the use of ab154846 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 41 kDa. Dilute primary antibody in 1% BSA
  • Application notes
    Is unsuitable for ICC/IF,IHC-P or IP.
  • Target

    Images

    • All lanes : Anti-G Protein alpha x+z antibody [EPR8654] (ab154846) at 1/1000 dilution

      Lane 1 : Human fetal brain lysate
      Lane 2 : Human cerebellum lysate
      Lane 3 : rat brain lysate
      Lane 4 : mouse brain lysate

      Lysates/proteins at 10 µg per lane.


      Predicted band size : 41 kDa

    References

    ab154846 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab154846.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up